CORMORANT ASSET MANAGEMENT, LP – MoonLake Immunotherapeutics Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$47.06M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+47.81%
quarter
MoonLake Immunotherapeutics 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 16.17M | $7.76 | 6.06M | |
| Q2 2022 | share | Increase | 0.00% | 6.06M shares | 30.88M | $5.25 | 6.06M |